Skip to content
Home/Companies/Healthcare/Parexel

Parexel

Healthcare·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Parexel?

Parexel is currently owned by EQT through EQT IX (2021 vintage), since 2021.

Hand-verified · updated 2026-08-18

EQT
Investor
EQT
EQT IX · 2021 · Buyout

Key facts

HQUnited States
SectorHealthcare
StatusActive

More from EQT IX

Other portfolio companies in the same fund.

idealista
Active
TMTUK· 2024
3Shape
Active
MedTechDenmark· 2022
Billtrust
Active
FintechUS· 2022
CFC
Active
InsurTechUK· 2022
SPT Labtech
Active
MedTechUK· 2022
United Talent Agency
Active
Business ServicesUS· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Parexel

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Parexel?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Parexel.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue